Abstract
The phosphatidylinositol 3-kinase (PI3K)/Akt and mitogen/extracellular signal-regulated kinase (MEK)/extracellular signal-regulated kinase (ERK) signaling pathways are important integrators of growth and survival signals originating from extracellular stimuli. We assessed the importance of these signaling pathways in the growth and survival of 8 breast cell lines (MCF10A, an immortalized line; and 7 cancer cell lines). The cell lines expressed variable levels of both phosphorylated ERK and phosphorylated Akt, but these were unchanged by incubation in serum-free medium. Despite continued activity of these pathways, the cells arrested growth in the absence of serum demonstrating that additional pathways are required for growth. Incubation with the PI3K inhibitor LY294002 suppressed growth of all cell lines, but most remained viable for at least 7–14 days. This long-term survival may be attributable to recovery of phospho-Akt by 24–48 h despite the continued presence of active LY294002, suggesting that alternate pathways may be activating Akt. In contrast, incubation with the MEK inhibitor U0126 not only arrested growth, but also killed all the cell lines within 2–4 days in the absence of serum; the presence of serum only slighted extended viability, except in MCF10A and MDA-MB-468 cells, in which serum provided significantly greater protection. It is likely that these signaling pathways control the level of pro-and anti-apoptotic proteins, yet assessment of Bcl-2 and Bcl-X showed dramatic reduction in level only when large numbers of cells were dead suggesting this may be a consequence rather than cause of death. Overall, the results demonstrate that the MEK/ERK pathway represents the more critical pathway for cell survival of these breast cancer cell lines, and suggest this pathways represents the better target for cancer therapy.
Similar content being viewed by others
References
MC Raff (1992) ArticleTitleSocial controls on cell survival and cell death Nature 356 397–400
H Dudek SR Datta MJ Brinbaum R Yao GM Cooper RA Segal DR Kaplan ME Greenberg (1997) ArticleTitleRegulation of neuronal survival by the serine–threonine protein kinase Akt Science 275 661–665
A Kauffmann-Zeh P Rodriquez-Viciana E Ulrich C Gilbert P Coffer J Downward G Evan (1997) ArticleTitleSuppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB Nature 385 544–548 Occurrence Handle10.1038/385544a0 Occurrence Handle9020362
SG Kennedy AJ Wagner SD Conzen J Jordan A Bellacosa PN Tsichlis N Hay (1997) ArticleTitleThe PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal Genes Dev 11 701–713 Occurrence Handle9087425
B Vanhaesebroeck DR Alessi (2000) ArticleTitleThe PI3K–PDK1 connection: more than just a road to PKB Biochem J 346 561–576 Occurrence Handle10.1042/0264-6021:3460561 Occurrence Handle10698680
SR Datta A Brunet ME Greenberg (1999) ArticleTitleCellular survival: a play in three Akts Genes Dev 13 2905–2927 Occurrence Handle10.1101/gad.13.22.2905 Occurrence Handle10579998
ES Kandel N Hay (1999) ArticleTitleThe regulation and activities of the multifunctional serine/threonine kinase Akt/PKB Exp Cell Res 253 210–229 Occurrence Handle10.1006/excr.1999.4690 Occurrence Handle10579924
TA Stadheim H Xiao A Eastman (2001) ArticleTitleThe inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells Cancer Res 61 1533–1540 Occurrence Handle11245462
P Blume-Jensen T Hunter (2001) ArticleTitleOncogenic kinase signalling Nature 411 355–365 Occurrence Handle10.1038/35077225 Occurrence Handle11357143
D Harari Y Yarden (2000) ArticleTitleMolecular mechanisms underlying Erb2/HER2 action in breast cancer Oncogene 19 6102–6114 Occurrence Handle10.1038/sj.onc.1203973 Occurrence Handle11156523
V Papa V Pexxino A Constantino A Belfiore D Giuffrida L Frittitta GB Vannelli R Brand ID Goldfine R Vigneri (1990) ArticleTitleElevated insulin receptor content in human breast cancer J Clin Invest 86 1503–1510 Occurrence Handle2243127
V Papa B Gliozzo GM Clark WL McGuire D Moore Y Fujita-Yamaguchi R Vigneri ID Goldfine V Peaaino (1993) ArticleTitleInsulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer Cancer Res 53 3736–3740 Occurrence Handle8339284
MJ Mauro ME O’Dwyer BJ Druker (2000) ArticleTitleSTI571, a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia: validating the promise of molecularly targeted therapy Cancer Chemother Pharmacol 48 S77–S78 Occurrence Handle10.1007/s002800100310
GW Sledge KD Miller (2003) ArticleTitleExploiting the hallmarks of cancer. The future conquest of breast cancer Eur J Cancer 39 1668–1675 Occurrence Handle10.1016/S0959-8049(03)00273-9 Occurrence Handle12888360
RJ Kreitman WH Wilson K Bergeron M Raggio M Stetler-Stevenson DJ Fitzgerald I Pastan (2001) ArticleTitleEfficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia N Eng J Med 345 241–247 Occurrence Handle10.1056/NEJM200107263450402
A Jemal T Murray A Samuels A Ghafoor E Ward MJ Thun (2003) ArticleTitleCancer statistics CA Cancer J Clin 53 5–26 Occurrence Handle12568441
I Vivanco CL Sawyers (2002) ArticleTitleThe phosphatidylinositol 3-kinase-AKT pathway in human cancer Nature Rev Cancer 2 489–501 Occurrence Handle10.1038/nrc839
R Rago J Mitchen G Wilding (1990) ArticleTitleDNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water Anal Biochem 191 31–34 Occurrence Handle10.1016/0003-2697(90)90382-J Occurrence Handle1706565
K Yu L Toral-Barza C Discafani WG Zhang J Skotnicki P Frost JJ Gibbons (2001) ArticleTitlemTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer Endocr Relat Cancer 8 249–258 Occurrence Handle10.1677/erc.0.0080249 Occurrence Handle11566616
J Brognard AS Clark Y Ni PA Dennis (2001) ArticleTitleAkt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation Cancer Res 61 3986–3997 Occurrence Handle11358816
AS Clark K West S Streicher PA Dennis (2002) ArticleTitleConstitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells Mol Cancer Therapat 1 707–717
DJ Slamon GM Clark SG Wong WJ Levin A Ullrich WL McGuire (1987) ArticleTitleHuman breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235 177–181
DJ Slamon W Godolphin LA Jones JA Holt SG Wong DE Keith WJ Levin SG Stuart J Udove A Ullrich (1989) ArticleTitleStudies of the HER-2/neu proto-oncogene in human breast and ovarian cancer Science 244 707–712
JRC Sainsbury GV Sherbet JR Farndon AL Harris (1985) ArticleTitleEpidermal-growth-factor receptors and oestrogen receptors in human breast cancer Lancet 325 364–366 Occurrence Handle10.1016/S0140-6736(85)91385-6
RK Hansen MJ Bissell (2000) ArticleTitleTissue architecture and breast cancer: the role of extracelllular matrix and steroid hormones Endocr Relat Cancer 7 95–113 Occurrence Handle10.1677/erc.0.0070095 Occurrence Handle10903527
M Hori S Inagawa J Shimazaki M Itabashi (2000) ArticleTitleOverexpression of mitogen-activated protein kinase superfamily proteins unrelated to Ras and AF-1 of estrogen receptor alpha mutation in advanced stage of human breast cancer Pathol Res Pract 196 817–826 Occurrence Handle11156322
SC Kozma ME Bogaard K Buser SM Saurer JL Bos B Groner NE Hynes (1987) ArticleTitleThe human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MB231 Nucl Acids Res 15 5963–5971 Occurrence Handle3627975
SP Davies H Reddy M Caivano P Cohen (2000) ArticleTitleSpecificity and mechanism of action of some commonly used protein kinase inhibitors Biochem J 351 95–105 Occurrence Handle10.1042/0264-6021:3510095 Occurrence Handle10998351
N Filippa CL Sable C Filloux B Hemmings E Obberghen ParticleVan (1999) ArticleTitleMechanisms of protein kinase B activation by cyclic AMP-dependent protein kinase Mol Cell Biol 19 4989–5000 Occurrence Handle10373549
S Yano H Tokumitsu TR Soderling (1998) ArticleTitleCalcium promotes cell survival through CaM-K kinase activation of the protein-kinase B pathway Nature 396 584–587
U Hermanto CS Zong L-H Wang (2000) ArticleTitleInhibition of mitogen-activated protein kinase selectively inhibits cell proliferation in human breast cancer cells displaying enhanced insulin-like growth factor 1-mediated mitogen-activated protein kinase activation Cell Growth Differ 11 655–664 Occurrence Handle11149601
MJ Boucher J Morisset PH Vachon JC Reed J Laine N Rivard (2000) ArticleTitleMEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-XL, and Mcl-1 and promotes survival of human pancreatic cancer cells J Cell Biochem 79 3555–369 Occurrence Handle10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.0.CO;2-0
E Berra MT Diaz-Mecco J Moscat (1998) ArticleTitleThe activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway J Biol Chem 273 10792–10797
J Brognard PA Dennis (2002) ArticleTitleVariable apoptotic response of NSCLC cells to inhibition of the MEK/ERK pathway by small molecules or dominant negative mutants Cell Death Differ 9 893–904 Occurrence Handle10.1038/sj.cdd.4401054 Occurrence Handle12181740
S Cory JM Adams (2002) ArticleTitleThe Bcl-2 family: regulators of the cellular life-or-death switch Nature Rev Cancer 2 647–656 Occurrence Handle10.1038/nrc883
Y Hu WH Dragowska A Wallis V Duronio L Mayer (2001) ArticleTitleCytotoxicity induced by manipulation of signal transduction pathways is associated with down-regulation of Bcl-2 but not Mcl-1 in MCF-7 human breast cancer Breast Cancer Res Treat 70 11–20 Occurrence Handle10.1023/A:1012564620853 Occurrence Handle11767000
S Haldar N Jena CM Croce (1995) ArticleTitleInactivation of Bcl-2 by phosphorylation Proc Natl Acad Sci USA 92 4507–4511 Occurrence Handle7753834
T Ito X Deng B Carr WS May (1997) ArticleTitleBcl-2 phosphorylation required for anti-apoptosis function J Biol Chem 272 11671–11673 Occurrence Handle9115213
PP Ruvolo X Deng WS May (2001) ArticleTitlePhosphorylation of Bcl2 and regulation of apoptosis Leukemia 15 515–522 Occurrence Handle10.1038/sj.leu.2402197 Occurrence Handle11368354
MP Scheid KM Schubert V Durinio (1999) ArticleTitleRegulation of Bad phosphorylation and association with Bcl-XL by the MAPK/Erk kinase J Biol Chem 274 31108–31113
SR Datta H Dudek X Tao S Masters H Fu Y Gotoh ME Greenberg (1997) ArticleTitleAkt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery Cell 91 231–241 Occurrence Handle10.1016/S0092-8674(00)80405-5 Occurrence Handle9346240
N Donovan EBE Becker Y Konishi A Bonni (2002) ArticleTitleJNK phosphorylation and activation of BAD couples the stress-activated signaling pathway to the cell death machinery J Biol Chem 277 40944–40949 Occurrence Handle10.1074/jbc.M206113200 Occurrence Handle12189144
M Maemura SK Akiyama VL Woods RB Dickson (1995) ArticleTitleExpression and ligand binding of alpha 2 beta 1 integrin on breast carcinoma cells Clin Exp Metastasis 13 223–235 Occurrence Handle10.1007/BF00133478 Occurrence Handle7606885
G Zugmaier BW Ennis B Deschauer D Katz C Knabbe G Wilding P Daly ME Lippman RB Dickson (1989) ArticleTitleTransforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines J Cell Physiol 141 353–361 Occurrence Handle10.1002/jcp.1041410217 Occurrence Handle2808542
J Filmus MN Pollak R Cailleau RN Buick (1985) ArticleTitleMDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF Biochem Biophys Res Commun 128 898–905 Occurrence Handle2986629
CL Arteaga SD Hurd TC Dugger AR Winnier JB Robertson (1994) ArticleTitleEpidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein Cancer Res 54 4703–4709 Occurrence Handle8062268
KB Reddy VG Keshamouni YQ Chen (1999) ArticleTitleThe level of tyrosine kinase activity regulates the expression of p21/WAF1 in cancer cells Int J Oncol 15 301–306 Occurrence Handle10402241
A Esparis-Ogando E Diaz-Rodriguez JC Montero L Yuste P Crespo A Pandiella (2002) ArticleTitleErk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2 Mol Cell Biol 22 270–285 Occurrence Handle10.1128/MCB.22.1.270-285.2002 Occurrence Handle11739740
W Nieves-Niera (1999) ArticleTitleApoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI Anticancer Drug Screen multifactorial relationships with topoisomerase I, protein kinase C, Bcl-2, p53, MDM-2 and caspase pathways Int J Cancer 82 396–404 Occurrence Handle10.1002/(SICI)1097-0215(19990730)82:3<396::AID-IJC13>3.0.CO;2-Z Occurrence Handle10399957
J Li C Yen D Liaw K Podsyanina S Bose SI Wang J Puc C Miliaresis L Rodgers R McCombie SH Bigner BC Giovanella M Ittmann B Tycko H Hibshoosh MH Wigler R Parsons (1997) ArticleTitlePTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 1876–1878 Occurrence Handle10.1126/science.275.5308.1943 Occurrence Handle9122687
LP Weng WM Smith PL Dahia U Ziebold E Gil JA Lees C Eng (1999) ArticleTitlePTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death Cancer Res 59 5808–5814
Y Lu YZ Lin R LaPushin B Cuevas X Fang SX Yu MA Davies H Khan T Furui M Mao R Zinner MC Hung P Steck K Siminovitch GB Mills (1999) ArticleTitleThe PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells Oncogene 18 7034–7045 Occurrence Handle10.1038/sj.onc.1203183 Occurrence Handle10597304
A Perren LP Weng AH Boag U Ziebold K Thakore PL Dahia P Komminoth JA Lees LM Mulligan GL Mutter C Eng (1999) ArticleTitleImmunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast Am J Pathol 155 1253–1260 Occurrence Handle10514407
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ripple, M.O., Kalmadi, S. & Eastman, A. Inhibition of Either Phosphatidylinositol 3-kinase/Akt or the Mitogen/Extracellular-regulated Kinase, MEK/ERK, Signaling Pathways Suppress Growth of Breast Cancer Cell Lines, but MEK/ERK Signaling is Critical for Cell Survival. Breast Cancer Res Treat 93, 177–188 (2005). https://doi.org/10.1007/s10549-005-4794-6
Issue Date:
DOI: https://doi.org/10.1007/s10549-005-4794-6